Literature DB >> 33669130

Assessment of Stress, Depressive and Anxiety Symptoms in Patients with COPD during In-Hospital Pulmonary Rehabilitation: An Observational Cohort Study.

Adam Wrzeciono1, Oliver Czech1, Katarzyna Buchta1, Sabina Zabłotni1, Edyta Gos1, Łukasz Tłuczykont1, Dagmara Górecka1, Agnieszka Pastuła1, Mateusz Adamczyk1, Ewa Jach1, Igor Świerkowski1, Patryk Szary2, Jan Szczegielniak3.   

Abstract

Background and
Objectives: The relationship between physical health and mental health has been considered for years. A number of studies have shown a correlation between depressive states and the progress of somatic diseases. It seems that the proper cooperation of specialists may result in the improvement of the patient's well-being and a positive effect on the course of the rehabilitation process. The aim of this study was to assess the symptoms of depression, anxiety, and stress in patients with chronic obstructive pulmonary disease (COPD) as well as the assessment of the relationship of psychological symptoms with sociodemographic factors and physical condition. Materials and
Methods: The study enrolled 51 COPD patients who underwent a three-week pulmonary rehabilitation program. After admission to the rehabilitation department, the subjects were asked to complete the Hospital Anxiety and Depression Scale (HADS) questionnaire, the Perception of Stress Questionnaire (PSQ), and a sociodemographic questionnaire.
Results: Anxiety states were diagnosed in 70% of respondents and depressive states were diagnosed in 54% of patients. Some of the respondents (14%) also showed a tendency to experience various grounded stresses. Additionally, there were correlations between the mental state and the results of fitness and respiratory tests. Conclusions: Patients with COPD are at risk for mental disorders, which may adversely affect their general health and significantly limit their physical and respiratory efficiencies. The development of widely available therapeutic solutions to reduce symptoms associated with depression, anxiety, and stress seems to be an important challenge for the management of patients with COPD.

Entities:  

Keywords:  behavioral symptoms; emotions; pulmonary rehabilitation; respiratory disease

Year:  2021        PMID: 33669130      PMCID: PMC7996584          DOI: 10.3390/medicina57030197

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  47 in total

1.  Effectiveness of pulmonary rehabilitation in elderly patients with COPD: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Weitong Li; Yalou Pu; Aifeng Meng; Xiaoxu Zhi; Guihua Xu
Journal:  Int J Nurs Pract       Date:  2019-07-02       Impact factor: 2.066

2.  Effectiveness of cognitive behavioural therapy in a community-based pulmonary rehabilitation programme: A controlled clinical trial.

Authors:  Edwin K Luk; Alexandra Gorelik; Louis Irving; Fary Khan
Journal:  J Rehabil Med       Date:  2017-03-06       Impact factor: 2.912

3.  The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD.

Authors:  Andreas von Leupoldt; Karin Taube; Kirsten Lehmann; Anja Fritzsche; Helgo Magnussen
Journal:  Chest       Date:  2011-03-31       Impact factor: 9.410

4.  Effect of Baseline Anxiety and Depression Symptoms on Selected Outcomes Following Pulmonary Rehabilitation.

Authors:  Kate Cullen; Daniel Talbot; Julie Gillmor; Colin McGrath; Rory OʼDonnell; Maria Baily-Scanlan; Julie Broderick
Journal:  J Cardiopulm Rehabil Prev       Date:  2017-07       Impact factor: 2.081

Review 5.  Anxiety and depression in COPD: current understanding, unanswered questions, and research needs.

Authors:  Janet Maurer; Venkata Rebbapragada; Soo Borson; Roger Goldstein; Mark E Kunik; Abebaw M Yohannes; Nicola A Hanania
Journal:  Chest       Date:  2008-10       Impact factor: 9.410

6.  Effect of a Pulmonary Rehabilitation Program on the levels of anxiety and depression and on the quality of life of patients with chronic obstructive pulmonary disease.

Authors:  C C da Costa; C de Azeredo Lermen; C Colombo; D B Canterle; M L L Machado; A Kessler; P J Z Teixeira
Journal:  Rev Port Pneumol       Date:  2014-05-27

7.  The links between chronic obstructive pulmonary disease and comorbid depressive symptoms: role of IL-2 and IFN-γ.

Authors:  Joanna Rybka; S Mechiel Korte; Małgorzata Czajkowska-Malinowska; Małgorzata Wiese; Kornelia Kędziora-Kornatowska; Józef Kędziora
Journal:  Clin Exp Med       Date:  2015-09-24       Impact factor: 3.984

8.  Managing respiratory disease.

Authors:  Sarah Lunn; Louise Restrick; Myra Stern
Journal:  Chron Respir Dis       Date:  2017-02       Impact factor: 2.444

9.  A pulmonary rehabilitation program reduces levels of anxiety and depression in COPD patients.

Authors:  Athanasios Tselebis; Dionisios Bratis; Argiro Pachi; Georgios Moussas; Ioannis Ilias; Maria Harikiopoulou; Elpida Theodorakopoulou; Silvia Dumitru; Epaminondas Kosmas; Alexandros Vgontzas; Nikolaos Siafakas; Nikolaos Tzanakis
Journal:  Multidiscip Respir Med       Date:  2013-06-22

Review 10.  Understanding the impact of symptoms on the burden of COPD.

Authors:  Marc Miravitlles; Anna Ribera
Journal:  Respir Res       Date:  2017-04-21
View more
  3 in total

1.  The Relationship Between Hospitalization Frequency of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Anxiety and Depression.

Authors:  Ding Wen-Tao; Chen Xue-Xiu; Chen Zun-Jiang; Chen Wei; Pan Cheng-Feng; Fan Xing-Ken
Journal:  Front Genet       Date:  2022-04-08       Impact factor: 4.772

2.  Proprietary Model of Qualification for In-Hospital Rehabilitation after COVID-19.

Authors:  Jan Szczegielniak; Anna Szczegielniak; Jacek Łuniewski; Katarzyna Bogacz
Journal:  Int J Environ Res Public Health       Date:  2022-08-22       Impact factor: 4.614

3.  Resilience and Subjectively Experienced Stress Among Paramedics Prior to and During the COVID-19 Pandemic.

Authors:  Andrzej Piotrowski; Ryszard Makarowski; Radu Predoiu; Alexandra Predoiu; Ole Boe
Journal:  Front Psychol       Date:  2021-07-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.